[Treatment of ocular tuberculosis-an update].
Larissa Christina BrönnimannStefan ZimmerliJustus Gerhard GarwegPublished in: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft (2020)
TU typically affects otherwise healthy individuals without extraocular manifestations. Early consideration of TU and initiation of ATT ideally before the start of systemic corticosteroids is decisive for long-term functional recovery. Treatment success, defined as absence of new uveitic flares within 6 months of treatment cessation, is to be expected in at least 82%. In cases of paradox worsening or lack of response, additional anti-inflammatory treatment is required.